Juvenile Arthritis

Juvenile Arthritis is arthritis that starts in children, usually before they turn 16. It's a type of chronic inflammation in the joints. This means the joints can become painful, stiff, and swollen. There are different types, but it's generally a long-term condition that needs ongoing management.

Condition

What people with Juvenile Arthritis report

Every report comes from a Lived member, sent anonymously.

Have you tried Methotrexate for Juvenile Arthritis?

NameHow it went

About Juvenile Arthritis

What It Is

Juvenile arthritis is arthritis that begins in childhood. Its most common form is juvenile idiopathic arthritis (JIA), an umbrella term for joint inflammation that starts before age 16, lasts at least six weeks and has no other identifiable cause (idiopathic means the cause is unknown). It is the most common long-term inflammatory joint condition of childhood, affecting roughly 1 in 1,000 children. The older name, juvenile rheumatoid arthritis (JRA), is still widely used. Inflamed joints become swollen, warm, stiff and painful, and they can lose range of motion. Young children often do not complain of pain. Instead, a parent may notice limping or clumsiness in the morning or after rest, reluctance to use an arm or leg, or a child who is less active than usual. Knees, hands and feet are commonly affected, but any joint can be, including the jaw and the spine. JIA is not one disease. Its types are grouped by how many joints are involved and what else happens in the body. Oligoarticular JIA affects four or fewer joints, often a knee, accounts for about half of cases and is more common in girls. Polyarticular JIA affects five or more joints; one form, in which a blood marker called rheumatoid factor is positive, closely resembles adult rheumatoid arthritis. Systemic JIA, also called Still's disease, combines arthritis with repeated high fevers and a pink rash that comes and goes, and it can affect internal organs. Enthesitis-related arthritis inflames the places where tendons attach to bone and can involve the lower back, while juvenile psoriatic arthritis occurs with the skin condition psoriasis, nail changes or a whole swollen finger or toe. The type matters because it shapes treatment, the risk of eye problems and the outlook.

Causes & Risk Factors

The cause of JIA is not known. Most types are autoimmune: the immune system, which normally fights infection, mistakenly attacks the body's own tissues, particularly the lining of the joints. Systemic JIA works differently. Many specialists regard it as autoinflammatory, driven by overactive inflammatory signals of the body's built-in defenses, which is why it responds to different medicines than the other types. Genes influence who is susceptible, but JIA is not usually passed directly from parent to child. Some links help explain particular types: a gene marker called HLA-B27 is associated with enthesitis-related arthritis, and a close family member with psoriasis is relevant to the psoriatic type. Childhood arthritis can also occur alongside other conditions, including inflammatory bowel disease, celiac disease, type 1 diabetes and Down syndrome. There is no known way to prevent JIA.

How It's Diagnosed

There is no single test for JIA, so diagnosis can take time. It rests on a careful history and examination showing joint swelling, or painful and limited movement, that has lasted at least six weeks, together with ruling out other causes. That last step matters because a swollen, painful joint in a child can also come from an infection, Lyme disease or, rarely, childhood cancer, each of which needs different treatment. Blood tests help sort out the type and look for alternatives. Markers of inflammation (the erythrocyte sedimentation rate and C-reactive protein) show how active inflammation is. Antinuclear antibody (ANA) does not diagnose JIA, but a positive result signals a higher risk of eye inflammation. Rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibody help identify the type that resembles adult rheumatoid arthritis, and the HLA-B27 gene marker points toward enthesitis-related arthritis. Any or all of these tests can be normal in a child who has JIA. A doctor may also draw fluid from a swollen joint with a needle to look for other causes, and X-rays or other imaging can show inflammation or damage. Because a common form of eye inflammation in JIA causes no symptoms, a complete eye examination by an ophthalmologist (eye specialist) is part of the workup even when the eyes look and feel normal.

Treatment Options

Treatment aims to bring inflammation under control quickly, ideally to the point where the disease is inactive, so that pain eases, joints keep their movement and damage to joints and growth is prevented. A pediatric rheumatologist usually leads care, working with physical and occupational therapists, eye specialists and nurses. The plan depends on the type of JIA and how many joints are involved. When only a few joints are affected, a steroid injection directly into each inflamed joint is a standard first step. It often gives lasting relief with few side effects, although younger children may need sedation for the procedure. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen can ease pain and stiffness, but they rarely control the disease on their own, so they are usually a short trial rather than a long-term plan. If arthritis persists or many joints are involved, disease-modifying antirheumatic drugs (DMARDs) are used to calm the immune attack on the joints. Methotrexate, taken by mouth or as an injection under the skin, is the usual first choice. When it is not enough or not tolerated, biologic medicines that block specific immune signals are added or substituted, most often tumor necrosis factor (TNF) blockers such as etanercept (Enbrel) or adalimumab (Humira). Because these medicines dampen parts of the immune system, they raise the risk of some infections, a trade-off weighed against the harm that uncontrolled arthritis does to joints, growth and eyesight. Systemic JIA is treated differently. Biologics that block the inflammatory signals interleukin-1 or interleukin-6, such as canakinumab (Ilaris) or tocilizumab (Actemra), are highly effective at controlling the fevers and rash and have greatly reduced the need for steroids. Steroid pills or infusions can bring severe inflammation under control quickly in any type, but long-term use is avoided in children because of its effects on bone health and growth. Physical and occupational therapy help maintain movement, strength and endurance, and splints or practical adjustments can make school tasks easier. Surgery, including joint replacement, is occasionally needed for a badly damaged joint.

What to Expect

The course of JIA varies widely between types and between children. In many children, especially those with only a few affected joints, the disease becomes inactive and causes little lasting joint damage. Arthritis in many joints is less likely to settle completely, and some people continue to have arthritis or need treatment as adults. Symptoms can also come and go: some children have only one or two flares, while others have symptoms that persist. Day to day, most children with well-controlled JIA can go to school and take part in sports, friendships and family life. Regular exercise such as walking, cycling or swimming keeps muscles strong and joints mobile. In the US, a Section 504 plan can provide accommodations at school. Ongoing pain, missed school and the routine of medicines and appointments can weigh on a child and family, and some children need emotional support along the way. Follow-up looks beyond the joints. JIA can slow a child's growth or make one arm or leg grow unevenly. Arthritis of the jaw joint can damage the joint and affect chewing even when it causes few symptoms, so specialists check for it. Eye checks continue on a schedule set by risk: about every three months for children at highest risk (for example, those with oligoarticular JIA who are ANA positive, were younger than 7 when arthritis began and were diagnosed within the past four years), and every 6 to 12 months for others. Chronic eye inflammation (uveitis) develops in roughly 10 to 20 percent of children with JIA, and if it is not controlled it can lead to cataracts, glaucoma and vision loss. Finding it early and treating it promptly protects sight. As teenagers approach adulthood, a planned move from pediatric to adult rheumatology care helps keep treatment from lapsing.

When to Seek Help

Arrange a medical evaluation if a child has a joint that stays swollen, a limp or morning stiffness that keeps returning, or ongoing reluctance to use an arm or leg. For a child already diagnosed, contact the care team if symptoms get worse, new joints become involved, treatment does not seem to be helping or a medicine causes troubling side effects. Keep routine eye screening appointments even when the eyes seem fine. Contact the care team or eye specialist promptly if an eye becomes red, painful or sensitive to light, or if vision changes. Children with enthesitis-related or psoriatic arthritis are especially prone to these sudden episodes of eye inflammation. A child with systemic JIA who has a persistent fever and seems markedly more unwell needs same-day medical assessment. This can be a sign of macrophage activation syndrome (MAS), a life-threatening overreaction of the immune system that needs urgent recognition and treatment. It can happen at any point in the illness and can be set off by an infection.

Questions to Ask Your Doctor

  1. 1.Which type of JIA does my child have, and how does that type affect treatment and the long-term outlook?
  2. 2.How often does my child need eye exams, and who will arrange them?
  3. 3.What is the goal of treatment, and how will we know whether it is working or needs to change?
  4. 4.What are the main trade-offs of the medicines you are recommending, and what monitoring will they need?
  5. 5.What support is available for school, physical activity and coping with pain or stress?

Last reviewed • Oct 2026

Educational content, not medical advice.